<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-07-15" modified="2020-10-07" version="219">
<accession>Q12888</accession>
<accession>F8VY86</accession>
<accession>Q2M1Z7</accession>
<accession>Q4LE46</accession>
<accession>Q5FWZ3</accession>
<accession>Q7Z3U4</accession>
<name>TP53B_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="55">TP53-binding protein 1</fullName>
<shortName evidence="53">53BP1</shortName>
<shortName evidence="53">p53-binding protein 1</shortName>
<shortName>p53BP1</shortName>
</recommendedName>
</protein>
<gene>
<name type="primary" evidence="58">TP53BP1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="26061" last="26068">
<title>Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2.</title>
<authorList>
<person name="Iwabuchi K."/>
<person name="Li B."/>
<person name="Massa H.F."/>
<person name="Trask B.J."/>
<person name="Date T."/>
<person name="Fields S."/>
</authorList>
<dbReference type="PubMed" id="9748285"/>
<dbReference type="DOI" id="10.1074/jbc.273.40.26061"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
<title>Preparation of a set of expression-ready clones of mammalian long cDNAs encoding large proteins by the ORF trap cloning method.</title>
<authorList>
<person name="Nakajima D."/>
<person name="Saito K."/>
<person name="Yamakawa H."/>
<person name="Kikuno R.F."/>
<person name="Nakayama M."/>
<person name="Ohara R."/>
<person name="Okazaki N."/>
<person name="Koga H."/>
<person name="Nagase T."/>
<person name="Ohara O."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
<source>
<tissue>Myeloid leukemia cell</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>VARIANTS GLU-353; SER-412 AND GLN-1136</scope>
<source>
<tissue>Cervix</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2005-01" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS GLU-353; SER-412; VAL-648; ARG-699; GLY-1014; ALA-1026; GLN-1136; GLY-1170 AND VAL-1174</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Nature" volume="440" first="671" last="675">
<title>Analysis of the DNA sequence and duplication history of human chromosome 15.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Sharpe T."/>
<person name="Young S.K."/>
<person name="Rowen L."/>
<person name="O'Neill K."/>
<person name="Whittaker C.A."/>
<person name="Kamal M."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Kodira C.D."/>
<person name="Madan A."/>
<person name="Qin S."/>
<person name="Yang X."/>
<person name="Abbasi N."/>
<person name="Abouelleil A."/>
<person name="Arachchi H.M."/>
<person name="Baradarani L."/>
<person name="Birditt B."/>
<person name="Bloom S."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Burke J."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dorris L. III"/>
<person name="Dors M."/>
<person name="Eichler E.E."/>
<person name="Engels R."/>
<person name="Fahey J."/>
<person name="Fleetwood P."/>
<person name="Friedman C."/>
<person name="Gearin G."/>
<person name="Hall J.L."/>
<person name="Hensley G."/>
<person name="Johnson E."/>
<person name="Jones C."/>
<person name="Kamat A."/>
<person name="Kaur A."/>
<person name="Locke D.P."/>
<person name="Madan A."/>
<person name="Munson G."/>
<person name="Jaffe D.B."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Mauceli E."/>
<person name="Naylor J.W."/>
<person name="Nesbitt R."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Ratcliffe A."/>
<person name="Rounsley S."/>
<person name="She X."/>
<person name="Sneddon K.M.B."/>
<person name="Stewart S."/>
<person name="Sougnez C."/>
<person name="Stone S.M."/>
<person name="Topham K."/>
<person name="Vincent D."/>
<person name="Wang S."/>
<person name="Zimmer A.R."/>
<person name="Birren B.W."/>
<person name="Hood L."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16572171"/>
<dbReference type="DOI" id="10.1038/nature04601"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Cerebellum</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1994" name="Proc. Natl. Acad. Sci. U.S.A." volume="91" first="6098" last="6102">
<title>Two cellular proteins that bind to wild-type but not mutant p53.</title>
<authorList>
<person name="Iwabuchi K."/>
<person name="Bartel P.L."/>
<person name="Li B."/>
<person name="Marraccino R."/>
<person name="Fields S."/>
</authorList>
<dbReference type="PubMed" id="8016121"/>
<dbReference type="DOI" id="10.1073/pnas.91.13.6098"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 946-1972</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="2708" last="2718">
<title>Negative cell cycle regulation and DNA-damage inducible phosphorylation of the BRCT protein 53BP1.</title>
<authorList>
<person name="Xia Z."/>
<person name="Morales J.C."/>
<person name="Dunphy W.G."/>
<person name="Carpenter P.B."/>
</authorList>
<dbReference type="PubMed" id="11042216"/>
<dbReference type="DOI" id="10.1074/jbc.m007665200"/>
</citation>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="J. Cell Biol." volume="153" first="613" last="620">
<title>Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways.</title>
<authorList>
<person name="Rappold I."/>
<person name="Iwabuchi K."/>
<person name="Date T."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="11331310"/>
<dbReference type="DOI" id="10.1083/jcb.153.3.613"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2002" name="Science" volume="298" first="1435" last="1438">
<title>53BP1, a mediator of the DNA damage checkpoint.</title>
<authorList>
<person name="Wang B."/>
<person name="Matsuoka S."/>
<person name="Carpenter P.B."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="12364621"/>
<dbReference type="DOI" id="10.1126/science.1076182"/>
</citation>
<scope>FUNCTION IN DNA DAMAGE CHECKPOINT</scope>
<scope>INTERACTION WITH CHEK2</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="36487" last="36495">
<title>Potential role for 53BP1 in DNA end-joining repair through direct interaction with DNA.</title>
<authorList>
<person name="Iwabuchi K."/>
<person name="Basu B.P."/>
<person name="Kysela B."/>
<person name="Kurihara T."/>
<person name="Shibata M."/>
<person name="Guan D."/>
<person name="Cao Y."/>
<person name="Hamada T."/>
<person name="Imamura K."/>
<person name="Jeggo P.A."/>
<person name="Date T."/>
<person name="Doherty A.J."/>
</authorList>
<dbReference type="PubMed" id="12824158"/>
<dbReference type="DOI" id="10.1074/jbc.m304066200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="Nature" volume="421" first="961" last="966">
<title>MDC1 is a mediator of the mammalian DNA damage checkpoint.</title>
<authorList>
<person name="Stewart G.S."/>
<person name="Wang B."/>
<person name="Bignell C.R."/>
<person name="Taylor A.M.R."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="12607005"/>
<dbReference type="DOI" id="10.1038/nature01446"/>
</citation>
<scope>INTERACTION WITH H2AX</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Cancer Res." volume="64" first="7216" last="7219">
<title>p53-Binding protein 1 is fused to the platelet-derived growth factor receptor beta in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorder.</title>
<authorList>
<person name="Grand F.H."/>
<person name="Burgstaller S."/>
<person name="Kuhr T."/>
<person name="Baxter E.J."/>
<person name="Webersinke G."/>
<person name="Thaler J."/>
<person name="Chase A.J."/>
<person name="Cross N.C."/>
</authorList>
<dbReference type="PubMed" id="15492236"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-04-2005"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH PDGFRB</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="Mol. Cell" volume="16" first="715" last="724">
<title>A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci.</title>
<authorList>
<person name="Riballo E."/>
<person name="Kuehne M."/>
<person name="Rief N."/>
<person name="Doherty A."/>
<person name="Smith G.C.M."/>
<person name="Recio M.-J."/>
<person name="Reis C."/>
<person name="Dahm K."/>
<person name="Fricke A."/>
<person name="Krempler A."/>
<person name="Parker A.R."/>
<person name="Jackson S.P."/>
<person name="Gennery A."/>
<person name="Jeggo P.A."/>
<person name="Loebrich M."/>
</authorList>
<dbReference type="PubMed" id="15574327"/>
<dbReference type="DOI" id="10.1016/j.molcel.2004.10.029"/>
</citation>
<scope>INTERACTION WITH DCLRE1C</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="Cell Cycle" volume="4" first="1834" last="1841">
<title>The GAR motif of 53BP1 is arginine methylated by PRMT1 and is necessary for 53BP1 DNA binding activity.</title>
<authorList>
<person name="Boisvert F.-M."/>
<person name="Rhie A."/>
<person name="Richard S."/>
<person name="Doherty A.J."/>
</authorList>
<dbReference type="PubMed" id="16294045"/>
<dbReference type="DOI" id="10.4161/cc.4.12.2250"/>
</citation>
<scope>METHYLATION</scope>
<scope>MUTAGENESIS OF ARG-1396; ARG-1398; ARG-1400; ARG-1401 AND ARG-1403</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DNA-BINDING</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="Cell Cycle" volume="4" first="1854" last="1861">
<title>53BP1 oligomerization is independent of its methylation by PRMT1.</title>
<authorList>
<person name="Adams M.M."/>
<person name="Wang B."/>
<person name="Xia Z."/>
<person name="Morales J.C."/>
<person name="Lu X."/>
<person name="Donehower L.A."/>
<person name="Bochar D.A."/>
<person name="Elledge S.J."/>
<person name="Carpenter P.B."/>
</authorList>
<dbReference type="PubMed" id="16294047"/>
<dbReference type="DOI" id="10.4161/cc.4.12.2282"/>
</citation>
<scope>METHYLATION</scope>
<scope>MUTAGENESIS OF ARG-1396; ARG-1398; ARG-1400; ARG-1401 AND ARG-1403</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DNA-BINDING</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-222; SER-294; SER-500; SER-635; SER-639; SER-640; SER-1094; SER-1219; SER-1362 AND SER-1678</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-834 AND SER-1426</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="DNA Repair" volume="6" first="1536" last="1544">
<title>Characterisation of the sites of DNA damage-induced 53BP1 phosphorylation catalysed by ATM and ATR.</title>
<authorList>
<person name="Jowsey P."/>
<person name="Morrice N.A."/>
<person name="Hastie C.J."/>
<person name="McLauchlan H."/>
<person name="Toth R."/>
<person name="Rouse J."/>
</authorList>
<dbReference type="PubMed" id="17553757"/>
<dbReference type="DOI" id="10.1016/j.dnarep.2007.04.011"/>
</citation>
<scope>PHOSPHORYLATION AT SER-166; SER-176; SER-178; SER-294; THR-302; SER-380; SER-452; SER-523; SER-552; SER-831; SER-1028; SER-1086; SER-1114 AND SER-1219</scope>
<scope>MUTAGENESIS OF 176-SER--SER-178</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-105; THR-302; SER-523; THR-543; THR-548; SER-552; SER-831; THR-855; THR-1214; SER-1216 AND SER-1219</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-222; SER-265; SER-395; SER-398; SER-500; SER-523; SER-525; SER-552; SER-809; SER-831; SER-1028; SER-1094; SER-1216; SER-1219; SER-1368; THR-1372; SER-1426; SER-1430; SER-1462; THR-1609; SER-1701 AND SER-1759</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="9845" last="9853">
<title>Protein phosphatase 5 regulates the function of 53BP1 after neocarzinostatin-induced DNA damage.</title>
<authorList>
<person name="Kang Y."/>
<person name="Lee J.H."/>
<person name="Hoan N.N."/>
<person name="Sohn H.M."/>
<person name="Chang I.Y."/>
<person name="You H.J."/>
</authorList>
<dbReference type="PubMed" id="19176521"/>
<dbReference type="DOI" id="10.1074/jbc.m809272200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-25 AND SER-1778</scope>
<scope>DEPHOSPHORYLATION AT SER-25 AND SER-1778 BY PPP5C</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="J. Cell. Physiol." volume="221" first="594" last="602">
<title>p8/nupr1 regulates DNA-repair activity after double-strand gamma irradiation-induced DNA damage.</title>
<authorList>
<person name="Gironella M."/>
<person name="Malicet C."/>
<person name="Cano C."/>
<person name="Sandi M.J."/>
<person name="Hamidi T."/>
<person name="Tauil R.M."/>
<person name="Baston M."/>
<person name="Valaco P."/>
<person name="Moreno S."/>
<person name="Lopez F."/>
<person name="Neira J.L."/>
<person name="Dagorn J.C."/>
<person name="Iovanna J.L."/>
</authorList>
<dbReference type="PubMed" id="19650074"/>
<dbReference type="DOI" id="10.1002/jcp.21889"/>
</citation>
<scope>INTERACTION WITH MSL1</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-294; SER-366; SER-380; SER-500; SER-523; SER-525; THR-543; SER-552; SER-834; SER-1028; SER-1114; SER-1426; SER-1430; SER-1460; SER-1462 AND SER-1474</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="Mol. Cell" volume="37" first="854" last="864">
<title>Regulation of chromatin architecture by the PWWP domain-containing DNA damage-responsive factor EXPAND1/MUM1.</title>
<authorList>
<person name="Huen M.S."/>
<person name="Huang J."/>
<person name="Leung J.W."/>
<person name="Sy S.M."/>
<person name="Leung K.M."/>
<person name="Ching Y.P."/>
<person name="Tsao S.W."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="20347427"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.12.040"/>
</citation>
<scope>INTERACTION WITH PWWP3A</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124; SER-294; SER-500; SER-525; SER-552; SER-566; SER-580; SER-639; SER-640; SER-809; THR-922; SER-970; SER-975; SER-1028; SER-1068; SER-1114; SER-1362; SER-1426; SER-1430; THR-1609; SER-1618 AND SER-1678</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="Biochem. Biophys. Res. Commun." volume="404" first="476" last="481">
<title>Protein phosphatase 5 is necessary for ATR-mediated DNA repair.</title>
<authorList>
<person name="Kang Y."/>
<person name="Cheong H.M."/>
<person name="Lee J.H."/>
<person name="Song P.I."/>
<person name="Lee K.H."/>
<person name="Kim S.Y."/>
<person name="Jun J.Y."/>
<person name="You H.J."/>
</authorList>
<dbReference type="PubMed" id="21144835"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.12.005"/>
</citation>
<scope>FUNCTION IN DNA DAMAGE RESPONSE</scope>
<scope>PHOSPHORYLATION AT SER-1778</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-222; SER-294; SER-500; SER-525; SER-552; SER-809; SER-1028; SER-1101; SER-1114; SER-1362; SER-1430; SER-1618 AND SER-1678</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2012" name="J. Cell Sci." volume="125" first="3529" last="3534">
<title>BRCA1-associated exclusion of 53BP1 from DNA damage sites underlies temporal control of DNA repair.</title>
<authorList>
<person name="Chapman J.R."/>
<person name="Sossick A.J."/>
<person name="Boulton S.J."/>
<person name="Jackson S.P."/>
</authorList>
<dbReference type="PubMed" id="22553214"/>
<dbReference type="DOI" id="10.1242/jcs.105353"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2013" name="Cell" volume="153" first="1266" last="1280">
<title>53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions.</title>
<authorList>
<person name="Callen E."/>
<person name="Di Virgilio M."/>
<person name="Kruhlak M.J."/>
<person name="Nieto-Soler M."/>
<person name="Wong N."/>
<person name="Chen H.T."/>
<person name="Faryabi R.B."/>
<person name="Polato F."/>
<person name="Santos M."/>
<person name="Starnes L.M."/>
<person name="Wesemann D.R."/>
<person name="Lee J.E."/>
<person name="Tubbs A."/>
<person name="Sleckman B.P."/>
<person name="Daniel J.A."/>
<person name="Ge K."/>
<person name="Alt F.W."/>
<person name="Fernandez-Capetillo O."/>
<person name="Nussenzweig M.C."/>
<person name="Nussenzweig A."/>
</authorList>
<dbReference type="PubMed" id="23727112"/>
<dbReference type="DOI" id="10.1016/j.cell.2013.05.023"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH RIF1 AND PAXIP1</scope>
<scope>MUTAGENESIS OF SER-6; SER-13; SER-25; SER-29; SER-105; SER-166; SER-176 AND SER-178</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63; SER-124; SER-222; SER-265; SER-294; SER-366; SER-380; SER-398; SER-500; SER-507; SER-518; SER-523; SER-525; SER-552; SER-580; SER-771; SER-809; SER-834; THR-922; SER-1028; THR-1056; SER-1068; SER-1094; SER-1114; SER-1148; SER-1216; SER-1219; SER-1317; SER-1342; SER-1362; SER-1426; SER-1430; SER-1462; THR-1609; SER-1618; SER-1635; THR-1638; THR-1648; SER-1656; SER-1673; SER-1678 AND SER-1701</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2013" name="Mol. Cell" volume="49" first="872" last="883">
<title>A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice.</title>
<authorList>
<person name="Escribano-Diaz C."/>
<person name="Orthwein A."/>
<person name="Fradet-Turcotte A."/>
<person name="Xing M."/>
<person name="Young J.T."/>
<person name="Tkac J."/>
<person name="Cook M.A."/>
<person name="Rosebrock A.P."/>
<person name="Munro M."/>
<person name="Canny M.D."/>
<person name="Xu D."/>
<person name="Durocher D."/>
</authorList>
<dbReference type="PubMed" id="23333306"/>
<dbReference type="DOI" id="10.1016/j.molcel.2013.01.001"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH RIF1</scope>
<scope>PHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF SER-6; SER-13; SER-25; SER-29; SER-105; SER-166; SER-176; SER-178; THR-302; SER-437; SER-452; SER-523; THR-543; SER-580; SER-625; SER-674; THR-696; SER-698; SER-784; SER-831; THR-855; SER-892; SER-1068; SER-1086; SER-1104; SER-1148; THR-1171 AND SER-1219</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2013" name="Nature" volume="499" first="50" last="54">
<title>53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark.</title>
<authorList>
<person name="Fradet-Turcotte A."/>
<person name="Canny M.D."/>
<person name="Escribano-Diaz C."/>
<person name="Orthwein A."/>
<person name="Leung C.C."/>
<person name="Huang H."/>
<person name="Landry M.C."/>
<person name="Kitevski-LeBlanc J."/>
<person name="Noordermeer S.M."/>
<person name="Sicheri F."/>
<person name="Durocher D."/>
</authorList>
<dbReference type="PubMed" id="23760478"/>
<dbReference type="DOI" id="10.1038/nature12318"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF ASP-1521; LYS-1613; ASP-1616; ILE-1617; LEU-1619; ASN-1621; LEU-1622; GLU-1624 AND ARG-1627</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2013" name="Proc. Natl. Acad. Sci. U.S.A." volume="110" first="2146" last="2151">
<title>Role of 53BP1 oligomerization in regulating double-strand break repair.</title>
<authorList>
<person name="Lottersberger F."/>
<person name="Bothmer A."/>
<person name="Robbiani D.F."/>
<person name="Nussenzweig M.C."/>
<person name="de Lange T."/>
</authorList>
<dbReference type="PubMed" id="23345425"/>
<dbReference type="DOI" id="10.1073/pnas.1222617110"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF SER-6; SER-13; SER-25; SER-29; SER-105; SER-166; SER-176; SER-178; THR-302; SER-437; SER-452; SER-523; THR-543; SER-580; SER-625; SER-674; THR-696; SER-698; SER-784; SER-831; THR-855; SER-892; SER-1068; SER-1086; SER-1104; SER-1148; THR-1171; SER-1219; 1398-ARG--ARG-1401 AND ASP-1521</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-294; SER-500; SER-552; SER-630; SER-692; SER-727; SER-1114; SER-1216 AND SER-1362</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2014" name="Mol. Cell" volume="54" first="512" last="525">
<title>Dephosphorylation enables the recruitment of 53BP1 to double-strand DNA breaks.</title>
<authorList>
<person name="Lee D.H."/>
<person name="Acharya S.S."/>
<person name="Kwon M."/>
<person name="Drane P."/>
<person name="Guan Y."/>
<person name="Adelmant G."/>
<person name="Kalev P."/>
<person name="Shah J."/>
<person name="Pellman D."/>
<person name="Marto J.A."/>
<person name="Chowdhury D."/>
</authorList>
<dbReference type="PubMed" id="24703952"/>
<dbReference type="DOI" id="10.1016/j.molcel.2014.03.020"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT THR-1609 AND SER-1618</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF THR-1609 AND SER-1618</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-930 AND LYS-1563</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-217; LYS-868; LYS-1434 AND LYS-1563</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-930</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1563</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-217; LYS-868; LYS-930; LYS-984; LYS-1365; LYS-1434 AND LYS-1563</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2017" name="Nature" volume="543" first="211" last="216">
<title>TIRR regulates 53BP1 by masking its histone methyl-lysine binding function.</title>
<authorList>
<person name="Drane P."/>
<person name="Brault M.E."/>
<person name="Cui G."/>
<person name="Meghani K."/>
<person name="Chaubey S."/>
<person name="Detappe A."/>
<person name="Parnandi N."/>
<person name="He Y."/>
<person name="Zheng X.F."/>
<person name="Botuyan M.V."/>
<person name="Kalousi A."/>
<person name="Yewdell W.T."/>
<person name="Muench C."/>
<person name="Harper J.W."/>
<person name="Chaudhuri J."/>
<person name="Soutoglou E."/>
<person name="Mer G."/>
<person name="Chowdhury D."/>
</authorList>
<dbReference type="PubMed" id="28241136"/>
<dbReference type="DOI" id="10.1038/nature21358"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NUDT16L1 AND RIF1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF TRP-1495; ASP-1521; THR-1609 AND SER-1618</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2018" name="EMBO J." volume="37">
<title>FAM35A associates with REV7 and modulates DNA damage responses of normal and BRCA1-defective cells.</title>
<authorList>
<person name="Tomida J."/>
<person name="Takata K.I."/>
<person name="Bhetawal S."/>
<person name="Person M.D."/>
<person name="Chao H.P."/>
<person name="Tang D.G."/>
<person name="Wood R.D."/>
</authorList>
<dbReference type="PubMed" id="29789392"/>
<dbReference type="DOI" id="10.15252/embj.201899543"/>
</citation>
<scope>INTERACTION WITH SHLD2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="3863" last="3872">
<title>Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor.</title>
<authorList>
<person name="Derbyshire D.J."/>
<person name="Basu B.P."/>
<person name="Serpell L.C."/>
<person name="Joo W.S."/>
<person name="Date T."/>
<person name="Iwabuchi K."/>
<person name="Doherty A.J."/>
</authorList>
<dbReference type="PubMed" id="12110597"/>
<dbReference type="DOI" id="10.1093/emboj/cdf383"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 1722-1971 IN COMPLEX WITH TP53</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2002" name="Genes Dev." volume="16" first="583" last="593">
<title>Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure.</title>
<authorList>
<person name="Joo W.S."/>
<person name="Jeffrey P.D."/>
<person name="Cantor S.B."/>
<person name="Finnin M.S."/>
<person name="Livingston D.M."/>
<person name="Pavletich N.P."/>
</authorList>
<dbReference type="PubMed" id="11877378"/>
<dbReference type="DOI" id="10.1101/gad.959202"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1714-1972 IN COMPLEX WITH TP53</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2004" name="Nature" volume="432" first="406" last="411">
<title>Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks.</title>
<authorList>
<person name="Huyen Y."/>
<person name="Zgheib O."/>
<person name="Ditullio R.A. Jr."/>
<person name="Gorgoulis V.G."/>
<person name="Zacharatos P."/>
<person name="Petty T.J."/>
<person name="Sheston E.A."/>
<person name="Mellert H.S."/>
<person name="Stavridi E.S."/>
<person name="Halazonetis T.D."/>
</authorList>
<dbReference type="PubMed" id="15525939"/>
<dbReference type="DOI" id="10.1038/nature03114"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1485-1602</scope>
<scope>INTERACTION WITH METHYLATED HISTONE H3 AND HISTONE H4</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF TRP-1495; TYR-1502 AND ASP-1521</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2006" name="Cell" volume="127" first="1361" last="1373">
<title>Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair.</title>
<authorList>
<person name="Botuyan M.V."/>
<person name="Lee J."/>
<person name="Ward I.M."/>
<person name="Kim J.-E."/>
<person name="Thompson J.R."/>
<person name="Chen J."/>
<person name="Mer G."/>
</authorList>
<dbReference type="PubMed" id="17190600"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.10.043"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.25 ANGSTROMS) OF 1484-1603 IN COMPLEX WITH HISTONE H4</scope>
<scope>SUBUNIT</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF TRP-1495; TYR-1500; TYR-1502; ASP-1521 AND TYR-1523</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<comment type="function">
<text evidence="21 27 35 41 42 43 44 45 46 48">Double-strand break (DSB) repair protein involved in response to DNA damage, telomere dynamics and class-switch recombination (CSR) during antibody genesis (PubMed:12364621, PubMed:22553214, PubMed:23333306, PubMed:17190600, PubMed:21144835, PubMed:28241136). Plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs and specifically counteracting the function of the homologous recombination (HR) repair protein BRCA1 (PubMed:22553214, PubMed:23727112, PubMed:23333306). In response to DSBs, phosphorylation by ATM promotes interaction with RIF1 and dissociation from NUDT16L1/TIRR, leading to recruitment to DSBs sites (PubMed:28241136). Recruited to DSBs sites by recognizing and binding histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites (PubMed:23760478, PubMed:28241136, PubMed:17190600). Required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (PubMed:23345425). Participates in the repair and the orientation of the broken DNA ends during CSR (By similarity). In contrast, it is not required for classic NHEJ and V(D)J recombination (By similarity). Promotes NHEJ of dysfunctional telomeres via interaction with PAXIP1 (PubMed:23727112).</text>
</comment>
<comment type="subunit">
<text evidence="21 25 26 27 28 31 32 34 35 39 40 43 44 45 46 49">Homoligomer (PubMed:16294047, PubMed:23760478, PubMed:23345425). Interacts with p53/TP53 (via the central domain) (PubMed:12110597, PubMed:11877378). Interacts with DCLRE1C (PubMed:15574327). Interacts with histone H2AX and this requires phosphorylation of H2AX on 'Ser-139' (PubMed:12607005). Interacts with histone H4 that has been dimethylated at 'Lys-20' (H4K20me2) (PubMed:17190600). Has low affinity for histone H4 containing monomethylated 'Lys-20' (H4K20me1) (PubMed:17190600). Does not bind histone H4 containing unmethylated or trimethylated 'Lys-20' (H4K20me3) (PubMed:17190600). Has low affinity for histone H3 that has been dimethylated on 'Lys-79' (PubMed:15525939). Has very low affinity for histone H3 that has been monomethylated on 'Lys-79' (in vitro) (PubMed:15525939). Does not bind unmethylated histone H3 (PubMed:15525939). Interacts with histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) (PubMed:23760478). Interacts with PWWP3A/EXPAND1 (PubMed:20347427). Interacts with CHEK2; modulates CHEK2 phosphorylation at 'Thr-68' in response to infrared (PubMed:12364621). Interacts with MSL1; this interaction may be required for MSL1 DNA repair activity, but not for histone acetyltransferase activity (PubMed:19650074). Interacts (when phosphorylated by ATM) with RIF1 (PubMed:23727112, PubMed:23333306, PubMed:28241136). Interacts (via the Tudor-like domain) with NUDT16L1/TIRR; interaction masks the Tudor-like domain and prevents recruitment to chromatin (PubMed:28241136). Interacts with PAXIP1 (PubMed:23727112). Interacts with IFI202A (By similarity). Interacts with SHLD2 (PubMed:29789392).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-11954519">
<id>Q49AR9</id>
<label>ANKS1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-495465">
<id>Q13315</id>
<label>ATM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-765407">
<id>P41182</id>
<label>BCL6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-349905">
<id>P38398</id>
<label>BRCA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-12809220">
<id>Q5SWW7</id>
<label>C10orf55</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-744556">
<id>Q96HB5</id>
<label>CCDC120</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-10192698">
<id>Q02930-3</id>
<label>CREB5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-494830">
<id>P16104</id>
<label>H2AX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-354552">
<id>P62807</id>
<label>H2BC8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-79722">
<id>P68431</id>
<label>H3C12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-302023">
<id>P62805</id>
<label>H4C9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-740220">
<id>O14964</id>
<label>HGS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-9478422">
<id>Q96G42</id>
<label>KLHDC7B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-748397">
<id>P50222</id>
<label>MEOX2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-447544">
<id>P01106</id>
<label>MYC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-78670">
<id>Q14686</id>
<label>NCOA6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-12813389">
<id>Q8TDS5</id>
<label>OXER1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-743225">
<id>Q6ZW49</id>
<label>PAXIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-748265">
<id>P78337</id>
<label>PITX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-476768">
<id>P53350</id>
<label>PLK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-12029004">
<id>P78424</id>
<label>POU6F2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-20592761">
<id>Q86V20-2</id>
<label>SHLD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-80140">
<id>P63165</id>
<label>SUMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-3939165">
<id>O43711</id>
<label>TLX3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-2514383">
<id>Q5T6F2</id>
<label>UBAP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-2107455">
<id>Q08AM6</id>
<label>VAC14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-1769146">
<id>Q99986</id>
<label>VRK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-347522">
<id>O43257</id>
<label>ZNHIT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-396540">
<id>Q12888</id>
</interactant>
<interactant intactId="EBI-1395317">
<id>Q6NZQ4</id>
<label>Paxip1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-8022649">
<id>Q12888-1</id>
</interactant>
<interactant intactId="EBI-302023">
<id>P62805</id>
<label>H4C9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-8022649">
<id>Q12888-1</id>
</interactant>
<interactant intactId="EBI-78670">
<id>Q14686</id>
<label>NCOA6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-8022649">
<id>Q12888-1</id>
</interactant>
<interactant intactId="EBI-80140">
<id>P63165</id>
<label>SUMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-8022649">
<id>Q12888-1</id>
</interactant>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>17</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="24 31 33 34 35 38 41 48 50">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="29 31 35 43 46 47 48">Chromosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="21">Chromosome</location>
<location evidence="21">Centromere</location>
<location evidence="21">Kinetochore</location>
</subcellularLocation>
<text evidence="21 35 43 46 48">Localizes to the nucleus in absence of DNA damage (PubMed:28241136). Following DNA damage, recruited to sites of DNA damage, such as double stand breaks (DSBs): recognizes and binds histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites (PubMed:23333306, PubMed:23760478, PubMed:24703952, PubMed:28241136, PubMed:17190600). Associated with kinetochores during mitosis (By similarity).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q12888-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q12888-2</id>
<name>2</name>
<sequence type="described" ref="VSP_018390"/>
</isoform>
<isoform>
<id>Q12888-3</id>
<name>3</name>
<sequence type="described" ref="VSP_018390 VSP_055062"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="35 48">The Tudor-like region mediates binding to histone H4 dimethylated at 'Lys-20' (H4K20me2) (PubMed:17190600). Interaction with NUDT16L1/TIRR masks the Tudor-like domain and prevents recruitment to chromatin (PubMed:28241136).</text>
</comment>
<comment type="domain">
<text evidence="46 47">The UDR (ubiquitin-dependent recruitment) motif specifically recognizes and binds histone H2A monoubiquitinated at 'Lys-15' (H2AK15ub) (PubMed:23760478, PubMed:24703952). Phosphorylation of the UDR blocks interaction with H2AK15ub (PubMed:24703952).</text>
</comment>
<comment type="PTM">
<text evidence="33 34">Asymmetrically dimethylated on Arg residues by PRMT1. Methylation is required for DNA binding.</text>
</comment>
<comment type="PTM">
<text evidence="23 24 36 38 41 43 45 47 48">Phosphorylated at basal level in the absence of DNA damage (PubMed:11042216, PubMed:11331310). Phosphorylated by ATM in response to DNA damage: phosphorylation at different sites promotes interaction with different set of proteins: phosphorylation at the N-terminus by ATM (residues from 6-178) promotes interaction with PAXIP1 and non-homologous end joining (NHEJ) of dysfunctional telomeres (PubMed:23727112). Phosphorylation by ATM at residues that are located more C-terminus (residues 300-650) leads to promote interaction with RIF1 (PubMed:23727112, PubMed:23333306, PubMed:28241136). Interaction with RIF1 leads to disrupt interaction with NUDT16L1/TIRR (PubMed:28241136). Phosphorylation at Thr-1609 and Ser-1618 in the UDR motif blocks interaction with H2AK15ub (PubMed:24703952). Dephosphorylated by PPP4C (PubMed:24703952). Hyperphosphorylation during mitosis correlates with its exclusion from chromatin and DNA lesions. Hyperphosphorylated in an ATR-dependent manner in response to DNA damage induced by UV irradiation (PubMed:17553757, PubMed:21144835). Dephosphorylated by PPP5C (PubMed:19176521).</text>
</comment>
<comment type="disease">
<text evidence="30">A chromosomal aberration involving TP53BP1 is found in a form of myeloproliferative disorder chronic with eosinophilia. Translocation t(5;15)(q33;q22) with PDGFRB creating a TP53BP1-PDGFRB fusion protein.</text>
</comment>
<comment type="sequence caution" evidence="55">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAE06107" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/tp53bp1/"/>
</comment>
<dbReference type="EMBL" id="AF078776">
<property type="protein sequence ID" value="AAC62018.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB210025">
<property type="protein sequence ID" value="BAE06107.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX537418">
<property type="protein sequence ID" value="CAD97660.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY904026">
<property type="protein sequence ID" value="AAW69392.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC018924">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC112161">
<property type="protein sequence ID" value="AAI12162.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U09477">
<property type="protein sequence ID" value="AAA21596.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10096.1">
<molecule id="Q12888-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45250.1">
<molecule id="Q12888-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45251.1">
<molecule id="Q12888-3"/>
</dbReference>
<dbReference type="PIR" id="I38604">
<property type="entry name" value="I38604"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001135451.1">
<molecule id="Q12888-3"/>
<property type="nucleotide sequence ID" value="NM_001141979.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001135452.1">
<molecule id="Q12888-2"/>
<property type="nucleotide sequence ID" value="NM_001141980.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005648.1">
<molecule id="Q12888-1"/>
<property type="nucleotide sequence ID" value="NM_005657.2"/>
</dbReference>
<dbReference type="PDB" id="1GZH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="B/D=1724-1972"/>
</dbReference>
<dbReference type="PDB" id="1KZY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="C/D=1714-1972"/>
</dbReference>
<dbReference type="PDB" id="1XNI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J=1485-1602"/>
</dbReference>
<dbReference type="PDB" id="2G3R">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.25"/>
<property type="chains" value="A=1484-1603"/>
</dbReference>
<dbReference type="PDB" id="2IG0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1484-1603"/>
</dbReference>
<dbReference type="PDB" id="2LVM">
<property type="method" value="NMR"/>
<property type="chains" value="A=1484-1603"/>
</dbReference>
<dbReference type="PDB" id="2MWO">
<property type="method" value="NMR"/>
<property type="chains" value="A=1484-1603"/>
</dbReference>
<dbReference type="PDB" id="2MWP">
<property type="method" value="NMR"/>
<property type="chains" value="A=1484-1603"/>
</dbReference>
<dbReference type="PDB" id="3LGF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=1484-1603"/>
</dbReference>
<dbReference type="PDB" id="3LGL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=1484-1603"/>
</dbReference>
<dbReference type="PDB" id="3LH0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=1484-1603"/>
</dbReference>
<dbReference type="PDB" id="4CRI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A/B=1459-1634"/>
</dbReference>
<dbReference type="PDB" id="4RG2">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A/B=1483-1606"/>
</dbReference>
<dbReference type="PDB" id="4X34">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=1484-1603"/>
</dbReference>
<dbReference type="PDB" id="5ECG">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="C/D=1713-1972"/>
</dbReference>
<dbReference type="PDB" id="5J26">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1487-1603"/>
</dbReference>
<dbReference type="PDB" id="5KGF">
<property type="method" value="EM"/>
<property type="resolution" value="4.54"/>
<property type="chains" value="K/L=1611-1631"/>
</dbReference>
<dbReference type="PDB" id="5Z78">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.76"/>
<property type="chains" value="C=1484-1603"/>
</dbReference>
<dbReference type="PDB" id="5ZCJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="C=1459-1634"/>
</dbReference>
<dbReference type="PDB" id="6CO1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.18"/>
<property type="chains" value="E/F=1484-1603"/>
</dbReference>
<dbReference type="PDB" id="6CO2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.49"/>
<property type="chains" value="C/D=1484-1603"/>
</dbReference>
<dbReference type="PDB" id="6IU7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="B=1665-1686"/>
</dbReference>
<dbReference type="PDB" id="6IUA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="B=1665-1686"/>
</dbReference>
<dbReference type="PDB" id="6MXX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J=1484-1603"/>
</dbReference>
<dbReference type="PDB" id="6MXY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.62"/>
<property type="chains" value="A/B=1484-1603"/>
</dbReference>
<dbReference type="PDB" id="6MXZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J=1484-1603"/>
</dbReference>
<dbReference type="PDB" id="6MY0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=1484-1603"/>
</dbReference>
<dbReference type="PDB" id="6RML">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.81"/>
<property type="chains" value="C=663-677"/>
</dbReference>
<dbReference type="PDB" id="6RMM">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.53"/>
<property type="chains" value="P/R=359-373"/>
</dbReference>
<dbReference type="PDB" id="6UPT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.96"/>
<property type="chains" value="A/B=1483-1606"/>
</dbReference>
<dbReference type="PDB" id="6VA5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.28"/>
<property type="chains" value="A=1483-1606"/>
</dbReference>
<dbReference type="PDB" id="6VIP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.36"/>
<property type="chains" value="A/B=1483-1606"/>
</dbReference>
<dbReference type="PDBsum" id="1GZH"/>
<dbReference type="PDBsum" id="1KZY"/>
<dbReference type="PDBsum" id="1XNI"/>
<dbReference type="PDBsum" id="2G3R"/>
<dbReference type="PDBsum" id="2IG0"/>
<dbReference type="PDBsum" id="2LVM"/>
<dbReference type="PDBsum" id="2MWO"/>
<dbReference type="PDBsum" id="2MWP"/>
<dbReference type="PDBsum" id="3LGF"/>
<dbReference type="PDBsum" id="3LGL"/>
<dbReference type="PDBsum" id="3LH0"/>
<dbReference type="PDBsum" id="4CRI"/>
<dbReference type="PDBsum" id="4RG2"/>
<dbReference type="PDBsum" id="4X34"/>
<dbReference type="PDBsum" id="5ECG"/>
<dbReference type="PDBsum" id="5J26"/>
<dbReference type="PDBsum" id="5KGF"/>
<dbReference type="PDBsum" id="5Z78"/>
<dbReference type="PDBsum" id="5ZCJ"/>
<dbReference type="PDBsum" id="6CO1"/>
<dbReference type="PDBsum" id="6CO2"/>
<dbReference type="PDBsum" id="6IU7"/>
<dbReference type="PDBsum" id="6IUA"/>
<dbReference type="PDBsum" id="6MXX"/>
<dbReference type="PDBsum" id="6MXY"/>
<dbReference type="PDBsum" id="6MXZ"/>
<dbReference type="PDBsum" id="6MY0"/>
<dbReference type="PDBsum" id="6RML"/>
<dbReference type="PDBsum" id="6RMM"/>
<dbReference type="PDBsum" id="6UPT"/>
<dbReference type="PDBsum" id="6VA5"/>
<dbReference type="PDBsum" id="6VIP"/>
<dbReference type="BMRB" id="Q12888"/>
<dbReference type="SMR" id="Q12888"/>
<dbReference type="BioGRID" id="113011">
<property type="interactions" value="424"/>
</dbReference>
<dbReference type="CORUM" id="Q12888"/>
<dbReference type="DIP" id="DIP-5978N"/>
<dbReference type="IntAct" id="Q12888">
<property type="interactions" value="329"/>
</dbReference>
<dbReference type="MINT" id="Q12888"/>
<dbReference type="STRING" id="9606.ENSP00000371475"/>
<dbReference type="BindingDB" id="Q12888"/>
<dbReference type="ChEMBL" id="CHEMBL2424509"/>
<dbReference type="iPTMnet" id="Q12888"/>
<dbReference type="MetOSite" id="Q12888"/>
<dbReference type="PhosphoSitePlus" id="Q12888"/>
<dbReference type="SwissPalm" id="Q12888"/>
<dbReference type="BioMuta" id="TP53BP1"/>
<dbReference type="DMDM" id="8928568"/>
<dbReference type="CPTAC" id="CPTAC-1014"/>
<dbReference type="CPTAC" id="CPTAC-1015"/>
<dbReference type="CPTAC" id="CPTAC-1334"/>
<dbReference type="CPTAC" id="CPTAC-2608"/>
<dbReference type="CPTAC" id="CPTAC-2609"/>
<dbReference type="EPD" id="Q12888"/>
<dbReference type="jPOST" id="Q12888"/>
<dbReference type="MassIVE" id="Q12888"/>
<dbReference type="MaxQB" id="Q12888"/>
<dbReference type="PaxDb" id="Q12888"/>
<dbReference type="PeptideAtlas" id="Q12888"/>
<dbReference type="PRIDE" id="Q12888"/>
<dbReference type="ProteomicsDB" id="29194"/>
<dbReference type="ProteomicsDB" id="59003">
<molecule id="Q12888-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="59004">
<molecule id="Q12888-2"/>
</dbReference>
<dbReference type="ABCD" id="Q12888">
<property type="antibodies" value="6 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="1749">
<property type="antibodies" value="896 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000263801">
<molecule id="Q12888-1"/>
<property type="protein sequence ID" value="ENSP00000263801"/>
<property type="gene ID" value="ENSG00000067369"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000382044">
<molecule id="Q12888-2"/>
<property type="protein sequence ID" value="ENSP00000371475"/>
<property type="gene ID" value="ENSG00000067369"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000450115">
<molecule id="Q12888-3"/>
<property type="protein sequence ID" value="ENSP00000393497"/>
<property type="gene ID" value="ENSG00000067369"/>
</dbReference>
<dbReference type="GeneID" id="7158"/>
<dbReference type="KEGG" id="hsa:7158"/>
<dbReference type="UCSC" id="uc001zrq.5">
<molecule id="Q12888-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7158"/>
<dbReference type="DisGeNET" id="7158"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000067369.13"/>
<dbReference type="GeneCards" id="TP53BP1"/>
<dbReference type="HGNC" id="HGNC:11999">
<property type="gene designation" value="TP53BP1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000067369">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="605230">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q12888"/>
<dbReference type="OpenTargets" id="ENSG00000067369"/>
<dbReference type="PharmGKB" id="PA36680"/>
<dbReference type="eggNOG" id="KOG3548">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000011891"/>
<dbReference type="HOGENOM" id="CLU_002167_0_0_1"/>
<dbReference type="InParanoid" id="Q12888"/>
<dbReference type="KO" id="K20915"/>
<dbReference type="OMA" id="PNMSPDD"/>
<dbReference type="OrthoDB" id="27155at2759"/>
<dbReference type="PhylomeDB" id="Q12888"/>
<dbReference type="TreeFam" id="TF350227"/>
<dbReference type="PathwayCommons" id="Q12888"/>
<dbReference type="Reactome" id="R-HSA-3232118">
<property type="pathway name" value="SUMOylation of transcription factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693565">
<property type="pathway name" value="Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693571">
<property type="pathway name" value="Nonhomologous End-Joining (NHEJ)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693607">
<property type="pathway name" value="Processing of DNA double-strand break ends"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69473">
<property type="pathway name" value="G2/M DNA damage checkpoint"/>
</dbReference>
<dbReference type="SIGNOR" id="Q12888"/>
<dbReference type="BioGRID-ORCS" id="7158">
<property type="hits" value="16 hits in 886 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="TP53BP1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q12888"/>
<dbReference type="GeneWiki" id="TP53BP1"/>
<dbReference type="GenomeRNAi" id="7158"/>
<dbReference type="Pharos" id="Q12888">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q12888"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 15"/>
</dbReference>
<dbReference type="RNAct" id="Q12888">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000067369">
<property type="expression patterns" value="Expressed in lung and 232 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q12888">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q12888">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0000777">
<property type="term" value="C:condensed chromosome kinetochore"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:1990391">
<property type="term" value="C:DNA repair complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016604">
<property type="term" value="C:nuclear body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000784">
<property type="term" value="C:nuclear chromosome, telomeric region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005657">
<property type="term" value="C:replication fork"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035861">
<property type="term" value="C:site of double-strand break"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003684">
<property type="term" value="F:damaged DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042393">
<property type="term" value="F:histone binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035064">
<property type="term" value="F:methylated histone binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002039">
<property type="term" value="F:p53 binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0001102">
<property type="term" value="F:RNA polymerase II activating transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042162">
<property type="term" value="F:telomeric DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003712">
<property type="term" value="F:transcription coregulator activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0061649">
<property type="term" value="F:ubiquitin modification-dependent histone binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071481">
<property type="term" value="P:cellular response to X-ray"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000077">
<property type="term" value="P:DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006303">
<property type="term" value="P:double-strand break repair via nonhomologous end joining"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000042">
<property type="term" value="P:negative regulation of double-strand break repair via homologous recombination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051091">
<property type="term" value="P:positive regulation of DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045830">
<property type="term" value="P:positive regulation of isotype switching"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051260">
<property type="term" value="P:protein homooligomerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.30.30.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10190">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="IDEAL" id="IID00123"/>
<dbReference type="InterPro" id="IPR015125">
<property type="entry name" value="53-BP1_Tudor"/>
</dbReference>
<dbReference type="InterPro" id="IPR001357">
<property type="entry name" value="BRCT_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036420">
<property type="entry name" value="BRCT_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR014722">
<property type="entry name" value="Rib_L2_dom2"/>
</dbReference>
<dbReference type="Pfam" id="PF09038">
<property type="entry name" value="53-BP1_Tudor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00292">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52113">
<property type="entry name" value="SSF52113"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50172">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0137">Centromere</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0995">Kinetochore</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="TP53-binding protein 1" id="PRO_0000072643">
<location>
<begin position="1"/>
<end position="1972"/>
</location>
</feature>
<feature type="domain" description="BRCT 1" evidence="22">
<location>
<begin position="1724"/>
<end position="1848"/>
</location>
</feature>
<feature type="domain" description="BRCT 2" evidence="22">
<location>
<begin position="1864"/>
<end position="1964"/>
</location>
</feature>
<feature type="region of interest" description="Tudor-like" evidence="56">
<location>
<begin position="1484"/>
<end position="1603"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with dimethylated histone H4" evidence="35">
<location>
<begin position="1495"/>
<end position="1523"/>
</location>
</feature>
<feature type="short sequence motif" description="GAR" evidence="33">
<location>
<begin position="1396"/>
<end position="1403"/>
</location>
</feature>
<feature type="short sequence motif" description="UDR" evidence="46">
<location>
<begin position="1604"/>
<end position="1631"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="1642"/>
<end position="1646"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="1760"/>
<end position="1764"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="38">
<location>
<position position="25"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="63"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="105"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 14">
<location>
<position position="124"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="36">
<location>
<position position="166"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="57">
<location>
<position position="176"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="57">
<location>
<position position="178"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 10 13 14">
<location>
<position position="222"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 14">
<location>
<position position="265"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 11 12 13 14 15 36">
<location>
<position position="294"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9 36">
<location>
<position position="302"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 14">
<location>
<position position="366"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 14 36">
<location>
<position position="380"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="395"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 14">
<location>
<position position="398"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="429"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="36">
<location>
<position position="452"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="464"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 10 11 12 13 14 15">
<location>
<position position="500"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="507"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="518"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 10 11 14 36">
<location>
<position position="523"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 11 12 13 14">
<location>
<position position="525"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9 11">
<location>
<position position="543"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9">
<location>
<position position="548"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 10 11 12 13 14 15 36">
<location>
<position position="552"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="566"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 14">
<location>
<position position="580"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="630"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="635"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 12">
<location>
<position position="639"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 12">
<location>
<position position="640"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="692"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="724"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="727"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="771"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 12 13 14">
<location>
<position position="809"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="830"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 10 36">
<location>
<position position="831"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 11 14">
<location>
<position position="834"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9">
<location>
<position position="855"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="12 14">
<location>
<position position="922"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="970"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="975"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 11 12 13 14 36">
<location>
<position position="1028"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="14">
<location>
<position position="1056"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 14">
<location>
<position position="1068"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="36">
<location>
<position position="1086"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 10 14">
<location>
<position position="1094"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="1101"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 12 13 14 15 36">
<location>
<position position="1114"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="1148"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9">
<location>
<position position="1214"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 10 14 15">
<location>
<position position="1216"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 9 10 14 36">
<location>
<position position="1219"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="1317"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="1342"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="21">
<location>
<position position="1355"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 12 13 14 15">
<location>
<position position="1362"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1368"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="1372"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 10 11 12 14">
<location>
<position position="1426"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 11 12 13 14">
<location>
<position position="1430"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="1460"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 11 14">
<location>
<position position="1462"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="1474"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10 12 14 47">
<location>
<position position="1609"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 13 14 47">
<location>
<position position="1618"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="1631"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="1635"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="14">
<location>
<position position="1638"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="14">
<location>
<position position="1648"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="1656"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="1673"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 12 13 14">
<location>
<position position="1678"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 14">
<location>
<position position="1701"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1759"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="38 41">
<location>
<position position="1778"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="16">
<location>
<position position="217"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="16 20">
<location>
<position position="217"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="16">
<location>
<position position="868"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="20">
<location>
<position position="868"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17 19 20">
<location>
<position position="930"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20">
<location>
<position position="984"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20">
<location>
<position position="1365"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="16">
<location>
<position position="1434"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="16 20">
<location>
<position position="1434"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="16">
<location>
<position position="1563"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="16 17 18 20">
<location>
<position position="1563"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_018390" evidence="52 54">
<original>M</original>
<variation>MPGEQM</variation>
<location>
<position position="1"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_055062" evidence="54">
<location>
<begin position="1692"/>
<end position="1693"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs560191." id="VAR_022172" evidence="37 51">
<original>D</original>
<variation>E</variation>
<location>
<position position="353"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs689647." id="VAR_022173" evidence="37 51">
<original>G</original>
<variation>S</variation>
<location>
<position position="412"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45443496." id="VAR_022174" evidence="51">
<original>M</original>
<variation>V</variation>
<location>
<position position="648"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34823068." id="VAR_022175" evidence="51">
<original>Q</original>
<variation>R</variation>
<location>
<position position="699"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34185035." id="VAR_034558">
<original>D</original>
<variation>G</variation>
<location>
<position position="841"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45470395." id="VAR_022176" evidence="51">
<original>E</original>
<variation>G</variation>
<location>
<position position="1014"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45482998." id="VAR_022177" evidence="51">
<original>V</original>
<variation>A</variation>
<location>
<position position="1026"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2602141." id="VAR_022178" evidence="37 51">
<original>K</original>
<variation>Q</variation>
<location>
<position position="1136"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34740611." id="VAR_034559">
<original>E</original>
<variation>K</variation>
<location>
<position position="1137"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45500399." id="VAR_022179" evidence="51">
<original>A</original>
<variation>G</variation>
<location>
<position position="1170"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3803339." id="VAR_022180" evidence="51">
<original>I</original>
<variation>V</variation>
<location>
<position position="1174"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2230449." id="VAR_034560">
<original>R</original>
<variation>Q</variation>
<location>
<position position="1442"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11554564." id="VAR_038689">
<original>G</original>
<variation>W</variation>
<location>
<position position="1488"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219. In 8A: Does not affect interaction with RIF1 and ability to promote immunoglobulin class-switch recombination (CSR), but abolishes interaction with PAXIP1 and ability to promote NHEJ of dysfunctional telomeres; when associated with A-13; A-25; A-29; A-105; A-166; A-176 and A-178." evidence="43 44 45">
<original>S</original>
<variation>A</variation>
<location>
<position position="6"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219. In 8A: Does not affect interaction with RIF1 and ability to promote immunoglobulin class-switch recombination (CSR), but abolishes interaction with PAXIP1 and ability to promote NHEJ of dysfunctional telomeres; when associated with A-6; A-25; A-29; A-105; A-166; A-176 and A-178." evidence="43 44 45">
<original>S</original>
<variation>A</variation>
<location>
<position position="13"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219. In 8A: Does not affect interaction with RIF1 and ability to promote immunoglobulin class-switch recombination (CSR), but abolishes interaction with PAXIP1 and ability to promote NHEJ of dysfunctional telomeres; when associated with A-6; A-13; A-29; A-105; A-166; A-176 and A-178." evidence="43 44 45">
<original>S</original>
<variation>A</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219. In 8A: Does not affect interaction with RIF1 and ability to promote immunoglobulin class-switch recombination (CSR), but abolishes interaction with PAXIP1 and ability to promote NHEJ of dysfunctional telomeres; when associated with A-6; A-13; A-25; A-105; A-166; A-176 and A-178." evidence="43 44 45">
<original>S</original>
<variation>A</variation>
<location>
<position position="29"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219. In 8A: Does not affect interaction with RIF1 and ability to promote immunoglobulin class-switch recombination (CSR), but abolishes interaction with PAXIP1 and ability to promote NHEJ of dysfunctional telomeres; when associated with A-6; A-13; A-25; A-29; A-166; A-176 and A-178." evidence="43 44 45">
<original>S</original>
<variation>A</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219. In 8A: Does not affect interaction with RIF1 and ability to promote immunoglobulin class-switch recombination (CSR), but abolishes interaction with PAXIP1 and ability to promote NHEJ of dysfunctional telomeres; when associated with A-6; A-13; A-25; A-29; A-105; A-176 and A-178." evidence="43 44 45">
<original>S</original>
<variation>A</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation site." evidence="36">
<original>SQS</original>
<variation>AQA</variation>
<location>
<begin position="176"/>
<end position="178"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219. In 8A: Does not affect interaction with RIF1 and ability to promote immunoglobulin class-switch recombination (CSR), but abolishes interaction with PAXIP1 and ability to promote NHEJ of dysfunctional telomeres; when associated with A-6; A-13; A-25; A-29; A-105; A-166 and A-178." evidence="43 44 45">
<original>S</original>
<variation>A</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219. In 8A: Does not affect interaction with RIF1 and ability to promote immunoglobulin class-switch recombination (CSR), but abolishes interaction with PAXIP1 and ability to promote NHEJ of dysfunctional telomeres; when associated with A-6; A-13; A-25; A-29; A-105; A-166 and A-176." evidence="43 44 45">
<original>S</original>
<variation>A</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219." evidence="43 44">
<original>T</original>
<variation>A</variation>
<location>
<position position="302"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219." evidence="43 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="437"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219." evidence="43 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="452"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219." evidence="43 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="523"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219." evidence="43 44">
<original>T</original>
<variation>A</variation>
<location>
<position position="543"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219." evidence="43 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="580"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219." evidence="43 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="625"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219." evidence="43 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="674"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219." evidence="43 44">
<original>T</original>
<variation>A</variation>
<location>
<position position="696"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219." evidence="43 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="698"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219." evidence="43 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="784"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-855; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219." evidence="43 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="831"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-892; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219." evidence="43 44">
<original>T</original>
<variation>A</variation>
<location>
<position position="855"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-1068; A-1086; A-1104; A-1148; A-1171 and A-1219." evidence="43 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="892"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1086; A-1104; A-1148; A-1171 and A-1219." evidence="43 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="1068"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1104; A-1148; A-1171 and A-1219." evidence="43 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="1086"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1148; A-1171 and A-1219." evidence="43 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="1104"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1171 and A-1219." evidence="43 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="1148"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148 and A-1219." evidence="43 44">
<original>T</original>
<variation>A</variation>
<location>
<position position="1171"/>
</location>
</feature>
<feature type="mutagenesis site" description="In 28A: Defects in recruitment to double strand breaks (DSBs), abolished interaction with RIF1 and abolished ability to repair DSBs; when associated with A-6; A-13; A-25; A-29; A-105; A-166; A-176; A-178; A-302; A-437; A-452; A-523; A-543; A-580; A-625; A-674; A-696; A-698; A-784; A-831; A-855; A-892; A-1068; A-1086; A-1104; A-1148 and A-1171." evidence="43 44">
<original>S</original>
<variation>A</variation>
<location>
<position position="1219"/>
</location>
</feature>
<feature type="mutagenesis site" description="No detectable effect on methylation by PRMT1 (in vitro). Loss of methylation; when associated with A-1398; A-1400; A-1401 and A-1403." evidence="33 34">
<original>R</original>
<variation>A</variation>
<location>
<position position="1396"/>
</location>
</feature>
<feature type="mutagenesis site" description="No detectable effect on methylation by PRMT1 (in vitro)." evidence="33 34">
<original>R</original>
<variation>K</variation>
<location>
<position position="1396"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on in class-switch recombination (CSR)." evidence="44">
<original>RGRR</original>
<variation>AGAA</variation>
<location>
<begin position="1398"/>
<end position="1401"/>
</location>
</feature>
<feature type="mutagenesis site" description="No detectable effect on methylation by PRMT1 (in vitro). Loss of methylation; when associated with A-1396; A-1400; A-1401 and A-1403." evidence="33 34">
<original>R</original>
<variation>A</variation>
<location>
<position position="1398"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced methylation by PRMT1 (in vitro). Strongly reduced methylation; when associated with K-1400. Strongly reduced methylation; when associated with K-1401." evidence="33 34">
<original>R</original>
<variation>K</variation>
<location>
<position position="1398"/>
</location>
</feature>
<feature type="mutagenesis site" description="No detectable effect on methylation by PRMT1 (in vitro). Loss of methylation; when associated with A-1396; A-1398; A-1401 and A-1403." evidence="33 34">
<original>R</original>
<variation>A</variation>
<location>
<position position="1400"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced methylation by PRMT1 (in vitro). Strongly reduced methylation; when associated with K-1398. Strongly reduced methylation; when associated with K-1401." evidence="33 34">
<original>R</original>
<variation>K</variation>
<location>
<position position="1400"/>
</location>
</feature>
<feature type="mutagenesis site" description="No detectable effect on methylation by PRMT1 (in vitro). Loss of methylation; when associated with A-1396; A-1398; A-1400 and A-1403." evidence="33 34">
<original>R</original>
<variation>A</variation>
<location>
<position position="1401"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced methylation by PRMT1 (in vitro). Strongly reduced methylation; when associated with K-1398. Strongly reduced methylation; when associated with K-1400." evidence="33 34">
<original>R</original>
<variation>K</variation>
<location>
<position position="1401"/>
</location>
</feature>
<feature type="mutagenesis site" description="No detectable effect on methylation by PRMT1 (in vitro). Loss of methylation; when associated with A-1396; A-1398; A-1400 and A-1401." evidence="33 34">
<original>R</original>
<variation>A</variation>
<location>
<position position="1403"/>
</location>
</feature>
<feature type="mutagenesis site" description="No detectable effect on methylation by PRMT1 (in vitro)." evidence="33 34">
<original>R</original>
<variation>K</variation>
<location>
<position position="1403"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with histone H4 that has been dimethylated at 'Lys-20' (H4K20me2). Abolishes recruitment to double strand breaks. Loss of interaction with histone H4 that has been dimethylated at 'Lys-20' (H4K20me2). Abolishes recruitment to double strand breaks; when associated with A-1521." evidence="31 35 48">
<original>W</original>
<variation>A</variation>
<variation>H</variation>
<location>
<position position="1495"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on recruitment to double strand breaks." evidence="31 35">
<original>W</original>
<variation>F</variation>
<location>
<position position="1495"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces recruitment to double strand breaks." evidence="31 35">
<original>W</original>
<variation>V</variation>
<location>
<position position="1495"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces affinity for histone H4 that has been dimethylated at 'Lys-20'." evidence="35">
<original>Y</original>
<variation>A</variation>
<location>
<position position="1500"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces affinity for histone H4 that has been dimethylated at 'Lys-20'." evidence="31 35">
<original>Y</original>
<variation>A</variation>
<location>
<position position="1502"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes recruitment to double strand breaks." evidence="31 35">
<original>Y</original>
<variation>L</variation>
<variation>Q</variation>
<location>
<position position="1502"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with histone H4 that has been dimethylated at 'Lys-20' (H4K20me2). Abolishes recruitment to double strand breaks. Loss of interaction with histone H4 that has been dimethylated at 'Lys-20' (H4K20me2). Abolishes recruitment to double strand breaks; when associated with A-1495." evidence="31 35 48">
<original>D</original>
<variation>A</variation>
<location>
<position position="1521"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes recruitment to double strand breaks and induces defects in class-switch recombination (CSR)." evidence="31 35 44 46">
<original>D</original>
<variation>R</variation>
<location>
<position position="1521"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases affinity for histone H4 that has been dimethylated at 'Lys-20'. No effect on recruitment to double strand breaks." evidence="35">
<original>Y</original>
<variation>A</variation>
<location>
<position position="1523"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases affinity for histone H4 that has been dimethylated at 'Lys-20'." evidence="35">
<original>Y</original>
<variation>S</variation>
<location>
<position position="1523"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutive recruitment to mitotic DNA lesions, leading to mitotic defects; when associated with A-1618." evidence="47">
<original>T</original>
<variation>A</variation>
<location>
<position position="1609"/>
</location>
</feature>
<feature type="mutagenesis site" description="Phosphomimetic mutant that abolishes recruitment to double strand breaks; when associated with D-1618." evidence="47">
<original>T</original>
<variation>E</variation>
<location>
<position position="1609"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect recruitment to double strand breaks." evidence="46">
<original>K</original>
<variation>A</variation>
<location>
<position position="1613"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect recruitment to double strand breaks." evidence="46">
<original>D</original>
<variation>A</variation>
<location>
<position position="1616"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced recruitment to double strand breaks. Defects in class-switch recombination (CSR)." evidence="46">
<original>I</original>
<variation>A</variation>
<location>
<position position="1617"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutive recruitment to mitotic DNA lesions, leading to mitotic defects; when associated with A-1609." evidence="47">
<original>S</original>
<variation>A</variation>
<location>
<position position="1618"/>
</location>
</feature>
<feature type="mutagenesis site" description="Phosphomimetic mutant that abolishes recruitment to double strand breaks; when associated with E-1609." evidence="47">
<original>S</original>
<variation>D</variation>
<location>
<position position="1618"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced recruitment to double strand breaks. Defects in class-switch recombination (CSR). Does not affect interaction with histone H4 dimethylated at 'Lys-20' (H4K20me2). Impaired interaction with histone H2A monoubiquitinated at 'Lys-15' (H2AK15ub)." evidence="46">
<original>L</original>
<variation>A</variation>
<location>
<position position="1619"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced recruitment to double strand breaks." evidence="46">
<original>N</original>
<variation>A</variation>
<location>
<position position="1621"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced recruitment to double strand breaks." evidence="46">
<original>L</original>
<variation>A</variation>
<location>
<position position="1622"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect recruitment to double strand breaks." evidence="46">
<original>E</original>
<variation>A</variation>
<location>
<position position="1624"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced recruitment to double strand breaks." evidence="46">
<original>R</original>
<variation>A</variation>
<location>
<position position="1627"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; CAD97660." ref="3" evidence="55">
<original>P</original>
<variation>S</variation>
<location>
<position position="796"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; CAD97660." ref="3" evidence="55">
<original>Y</original>
<variation>C</variation>
<location>
<position position="1600"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; CAD97660." ref="3" evidence="55">
<original>G</original>
<variation>R</variation>
<location>
<position position="1958"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1490"/>
<end position="1494"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="1496"/>
<end position="1498"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1501"/>
<end position="1511"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1514"/>
<end position="1519"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1524"/>
<end position="1528"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1529"/>
<end position="1531"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1532"/>
<end position="1535"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1543"/>
<end position="1547"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="1549"/>
<end position="1551"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1553"/>
<end position="1564"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1567"/>
<end position="1574"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1577"/>
<end position="1582"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1583"/>
<end position="1585"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1586"/>
<end position="1588"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1590"/>
<end position="1594"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1597"/>
<end position="1600"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="1674"/>
<end position="1676"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1715"/>
<end position="1719"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="1726"/>
<end position="1731"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1732"/>
<end position="1736"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1741"/>
<end position="1745"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1773"/>
<end position="1781"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="1782"/>
<end position="1784"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="1793"/>
<end position="1799"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1801"/>
<end position="1808"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1813"/>
<end position="1821"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1825"/>
<end position="1827"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1829"/>
<end position="1837"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1843"/>
<end position="1845"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1851"/>
<end position="1853"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="1854"/>
<end position="1857"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1858"/>
<end position="1860"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="1868"/>
<end position="1871"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1873"/>
<end position="1879"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="1881"/>
<end position="1884"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1885"/>
<end position="1894"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1898"/>
<end position="1908"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1914"/>
<end position="1916"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1918"/>
<end position="1922"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1928"/>
<end position="1937"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1944"/>
<end position="1953"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1963"/>
<end position="1965"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1GZH"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1KZY"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2G3R"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2LVM"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6IUA"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6VA5"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17525332"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P70399"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00033"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11042216"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11331310"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11877378"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12110597"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12364621"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12607005"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12824158"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15492236"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15525939"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15574327"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16294045"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16294047"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17190600"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17553757"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19176521"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19650074"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20347427"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21144835"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22553214"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23333306"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23345425"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23727112"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23760478"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24703952"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28241136"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29789392"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9748285"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="52" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9748285"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000303">
<source ref="2"/>
</evidence>
<evidence key="55" type="ECO:0000305"/>
<evidence key="56" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="17190600"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="17553757"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:11999"/>
</source>
</evidence>
<sequence length="1972" mass="213574" checksum="13E2CC8A265F9D2A" modified="2000-12-01" version="2">MDPTGSQLDSDFSQQDTPCLIIEDSQPESQVLEDDSGSHFSMLSRHLPNLQTHKENPVLDVVSNPEQTAGEERGDGNSGFNEHLKENKVADPVDSSNLDTCGSISQVIEQLPQPNRTSSVLGMSVESAPAVEEEKGEELEQKEKEKEEDTSGNTTHSLGAEDTASSQLGFGVLELSQSQDVEENTVPYEVDKEQLQSVTTNSGYTRLSDVDANTAIKHEEQSNEDIPIAEQSSKDIPVTAQPSKDVHVVKEQNPPPARSEDMPFSPKASVAAMEAKEQLSAQELMESGLQIQKSPEPEVLSTQEDLFDQSNKTVSSDGCSTPSREEGGCSLASTPATTLHLLQLSGQRSLVQDSLSTNSSDLVAPSPDAFRSTPFIVPSSPTEQEGRQDKPMDTSVLSEEGGEPFQKKLQSGEPVELENPPLLPESTVSPQASTPISQSTPVFPPGSLPIPSQPQFSHDIFIPSPSLEEQSNDGKKDGDMHSSSLTVECSKTSEIEPKNSPEDLGLSLTGDSCKLMLSTSEYSQSPKMESLSSHRIDEDGENTQIEDTEPMSPVLNSKFVPAENDSILMNPAQDGEVQLSQNDDKTKGDDTDTRDDISILATGCKGREETVAEDVCIDLTCDSGSQAVPSPATRSEALSSVLDQEEAMEIKEHHPEEGSSGSEVEEIPETPCESQGEELKEENMESVPLHLSLTETQSQGLCLQKEMPKKECSEAMEVETSVISIDSPQKLAILDQELEHKEQEAWEEATSEDSSVVIVDVKEPSPRVDVSCEPLEGVEKCSDSQSWEDIAPEIEPCAENRLDTKEEKSVEYEGDLKSGTAETEPVEQDSSQPSLPLVRADDPLRLDQELQQPQTQEKTSNSLTEDSKMANAKQLSSDAEAQKLGKPSAHASQSFCESSSETPFHFTLPKEGDIIPPLTGATPPLIGHLKLEPKRHSTPIGISNYPESTIATSDVMSESMVETHDPILGSGKGDSGAAPDVDDKLCLRMKLVSPETEASEESLQFNLEKPATGERKNGSTAVAESVASPQKTMSVLSCICEARQENEARSEDPPTTPIRGNLLHFPSSQGEEEKEKLEGDHTIRQSQQPMKPISPVKDPVSPASQKMVIQGPSSPQGEAMVTDVLEDQKEGRSTNKENPSKALIERPSQNNIGIQTMECSLRVPETVSAATQTIKNVCEQGTSTVDQNFGKQDATVQTERGSGEKPVSAPGDDTESLHSQGEEEFDMPQPPHGHVLHRHMRTIREVRTLVTRVITDVYYVDGTEVERKVTEETEEPIVECQECETEVSPSQTGGSSGDLGDISSFSSKASSLHRTSSGTSLSAMHSSGSSGKGAGPLRGKTSGTEPADFALPSSRGGPGKLSPRKGVSQTGTPVCEEDGDAGLGIRQGGKAPVTPRGRGRRGRPPSRTTGTRETAVPGPLGIEDISPNLSPDDKSFSRVVPRVPDSTRRTDVGAGALRRSDSPEIPFQAAAGPSDGLDASSPGNSFVGLRVVAKWSSNGYFYSGKITRDVGAGKYKLLFDDGYECDVLGKDILLCDPIPLDTEVTALSEDEYFSAGVVKGHRKESGELYYSIEKEGQRKWYKRMAVILSLEQGNRLREQYGLGPYEAVTPLTKAADISLDNLVEGKRKRRSNVSSPATPTASSSSSTTPTRKITESPRASMGVLSGKRKLITSEEERSPAKRGRKSATVKPGAVGAGEFVSPCESGDNTGEPSALEEQRGPLPLNKTLFLGYAFLLTMATTSDKLASRSKLPDGPTGSSEEEEEFLEIPPFNKQYTESQLRAGAGYILEDFNEAQCNTAYQCLLIADQHCRTRKYFLCLASGIPCVSHVWVHDSCHANQLQNYRNYLLPAGYSLEEQRILDWQPRENPFQNLKVLLVSDQQQNFLELWSEILMTGGAASVKQHHSSAHNKDIALGVFDVVVTDPSCPASVLKCAEALQLPVVSQEWVIQCLIVGERIGFKQHPKYKHDYVSH</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

